Noninvasive measurements of cardiac high-energy phosphate metabolites in dilated cardiomyopathy by using 31P spectroscopic chemical shift imaging

European Radiology

Volumn 15, Issue 2, 2005, Pages 319-323

  Hansch, Andreas ^a   Rzanny, R ^a   Heyne, J P ^a   Leder, U ^a   Reichenbach, J R ^a   Kaiser, W A ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Chemical shift imaging; Dilated cardiomyopathy; High energy phosphates; Spectroscopy

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; ADENOSINE TRIPHOSPHATE; CREATININE; PHOSPHATE; PHOSPHODIESTERASE; PHOSPHORUS 31;

ADULT; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENERGY METABOLISM; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH ENERGY PHOSPHATE; HUMAN; MALE; MEDICAL ASSESSMENT; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; SYMPTOM;

2,3-DIPHOSPHOGLYCERATE; ADENOSINE TRIPHOSPHATE; ADULT; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; OLIGONUCLEOTIDES; PHOSPHATES; PHOSPHOCREATINE; PHOSPHORUS ISOTOPES; STATISTICS, NONPARAMETRIC;

EID: 12544256759     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-004-2504-0     Document Type: Article

References (22)

1. Fatkin D, Graham RM (2002) Molecular mechanisms of inherited cardiomyopathies. Physiol Rev 82:945-980
2. Bottomley PA (1994) MR spectroscopy of the human heart: The status and the challenges. Radiology 191:593-612
3. Ingwall JS (1982) Phosphorus nuclear magnetic resonance spectroscopy of cardiac and skeletal muscles. Am J Physiol 242:729-744
4. Schaefer S, Gober J, Valenza M, Karczmar GS, Matson GB, Camacho SA, Botvinick EH, Massie B, Weiner MW (1988) Nuclear magnetic resonance imaging-guided phosphorus-31 spectroscopy of the human heart. J Am Coll Cardiol 12:1449-1455
5. Schaefer S, Massie B, Weiner MW (1989) Magnetic resonance spectroscopy of the heart. Cardiol Clin 7:697-712
6. Sandstede JJ (2003) Assessment of myocardial viability by MR imaging. Eur Radiol 13:52-61
7. Schaefer S, Gober JR, Schwartz GG, Twieg DB, Weiner MW, Massie B (1990) In vivo phosphorus-31 spectroscopic imaging in patients with global myocardial disease. Am J Cardiol 65:1154-1161
8. Auffermann W, Chew WM, Wolfe CL, Tavares NJ, Parmley WW, Semelka RC, Donnelly T, Chatterjee K, Higgins CB (1991) Normal and diffusely abnormal myocardium in humans: Functional and metabolic characterization with P-31 MR spectroscopy and cine MR imaging. Radiology 179:253-259
9. Masuda Y, Tateno Y, Ikehira H, Hashimoto T, Shishido F, Sekiya M, Imazeki Y, Imai H, Watanabe S, Inagaki Y (1992) High-energy phosphate metabolism of the myocardium in normal subjects and patients with various cardiomyopathies - the study using ECG gated MR spectroscopy with a localization technique. Jpn Circ J 56:620-626
10. Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G (1991) Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J 122:795-801
11. Neubauer S, Krahe T, Schindler R, Horn M, Hillenbrand H, Entzeroth C, Mader H, Kromer EP, Riegger GA, Lackner K et al (1992) 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 86:1810-1818
12. Bottomley PA, Hardy CJ (1992) Proton overhauser enhancements in human cardiac phosphorus NMR spectroscopy at 1.5 T. Magn Reson Med 24:384-390
13. Loffler R, Sauter R, Kolem H, Haase A, von Kienlin M (1998) Localized spectroscopy from anatomically matched compartments: Improved sensitivity and localization for cardiac 31P MRS in humans. J Magn Reson 134:287-299
14. Meininger M, Landschuetz W, Beer M, Seyfarth T, Horn M, Pabst T, Haase A, Hahn D, Neubauer S, von Kienlin M (1999) Concentrations of human cardiac phosphorus metabolites determined by SLOOP 31P NMR spectroscopy. Magn Reson Med 41:657-663
15. Rector TS, Cohn JN (1994) Prognosis in congestive heart failure. Annu Rev Med 45:341-350
16. Schaefer S (1990) Clinical nuclear magnetic resonance spectroscopy: insight into metabolism. Am J Cardiol 66:45-50
17. Krahe T, Schindler R, Neubauer S, Ertl G, Horn M, Lackner K (1993) 31P-cardio-MR-spectroscopy in myocardial insufficiency. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 159:64-70
18. Schindler R, Krahe T, Neubauer S, Hillenbrand H, Entzeroth C, Horn M, Lackner K, Ertl G (1992) The direct measurement of the spin-grid-relaxation times of phosphorus metabolites in the human myocardium. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 157:452-457
19. Ye Y, Gong G, Ochiai K, Liu J, Zhang J (2001) High-energy phosphate metabolism and creatine kinase in failing hearts: A new porcine model. Circulation 103:1570-1576
20. Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281:1309-1312
21. Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W, Pabst T, Ertl G, Hahn D, Ingwall JS, Kochsiek K (1997) Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96:2190-2196
22. van Dobbenburgh JO, Lekkerkerk C, van Echteld CJ, de Beer R (1994) Saturation correction in human cardiac 31P MR spectroscopy at 1.5 T. NMR Biomed 7:218-224